Rapport Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $155.4M
Liabilities Breakdown FY2023
Total Liabilities: $14.5M
Asset Breakdown
Total Assets: $155.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $70.2M | 45.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.9M | 1.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $83.3M | 53.6% |
Liabilities Breakdown
Total Liabilities: $14.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.5M | 17.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $12.0M | 82.7% |